drug
as of 2026-07-01N-acetylcysteine
N-Acetylcysteinen-acetylcysteine
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Yale University
9 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
9
A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine
NCT06546475Phase 4Not Yet Recruiting
Effects of NAC on Symptoms of CHR Patients
NCT05142735—Recruiting
Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine
NCT02505477Phase 4Completed
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
NCT03149107Phase 3Terminated
Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.
NCT03510741Phase 2Completed
Effect of N-acetylcysteine on Brain Glutamate
NCT02483130—Completed
N-acetylcysteine Effects on Tetrahydrocannabinol
NCT02335060Early Phase 1Terminated
N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis
NCT01354132Phase 2Completed
KOLs & investigators
9
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication
KOL
Mohini Ranganathan, MBBS
personKOL score 5
Prof Imran B Chaudhry, MD
personKOL score 5
Cenk Tek, MD
personKOL score 5
T. U. Wilson Woo, MD, PhD
personKOL score —